Når den individuelle patientrespons for alle de relevante kliniske symptomer er veletableret og stabil, kan dosis justeres med henblik på fortsat effektiv behandling, mens responsparametrene og patientens velbefindende fortsat omhyggeligt observeres.
Once individual patient response for all relevant clinical manifestations is well-established and stabilised, dosages may be adjusted for continued effective therapy, while continuing to closely monitor response parameters and patient well-being.